Acesis BioMed
About:
Acesis BioMed is a biomedical company that develops a platform of oral drug candidates for metabolic and endocrine disorders.
Website: https://acesisbio.com/
Top Investors: KreaMedica
Description:
Acesis BioMed is a biomedical company that develops a platform of oral drug candidates for metabolic and endocrine disorders. The company was co-founded by Costas Karatzas and Vassilios Papadopoulos and is headquartered in Lone Tree, Colorado.
Total Funding Amount:
$1.26M
Headquarters Location:
Denver, Colorado, United States
Founded Date:
2022-01-01
Founders:
Costas Karatzas, Vassilios Papadopoulos
Number of Employees:
1-10
Last Funding Date:
2023-01-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai